October 28 – 29, 2019

Healthcare Gets Personal

This year at MTIF is shaping up to be one of our most impactful yet! With top tier presenting companies, representatives from over 300 leading companies and exhibits and panels from around the world, this MTIF highlights the future of personalized healthcare in Medical Technology. This year, we’re introducing a new limited session that will allow attendees to directly with industry experts. You can learn more here

The Future of Medicine is Here

This year at MTIF is shaping up to be one of our most impactful yet! With top tier presenting companies, representatives from over 300 leading companies and exhibits and panels from around the world, this MTIF highlights the future of MedTech in Southern California.

MTIF 2019 Agenda

  • Oct. 28
  • Oct. 29
    07:00 - 08:15 AM
    Registration, Networking & Exhibits
    08:15 - 08:25 AM
    Welcome Address: Accelerating Success

    OCTANe CEO Bill Carpou opens up the 2019 Medical Technology Innovation Forum with a focus on the current MedTech ecosystem in Southern California and what the future holds for growth in Orange County

    08:30 - 09:15 AM
    Keynote: AI Med- Artificial Intelligence in Medicine

    Dr. Chang’s keynote will highlight common misconceptions about AI in medicine. Additionally, he will discuss the future of AI and the role it will play in the practice of medicine.

    Dr. Anthony C. Chang, MBA, MPH, MS, Pediatric Cardiology, Chief Intelligence & Innovation Officer, Sharon Disney Lund Medical Intelligence and Innovation Institute (MI3), CHOC Children’s

    09:15 - 10:00 AM
    Future of Healthcare- The Role of Personalized Medicine

    Better diagnoses, earlier interventions, more-efficient drug therapies, customized treatment plans. These are the promises of personalized medicine. Individualized, precision or personalized medicine provides a genomic blueprint to determine each person’s unique disease susceptibility, define preventive measures and enable targeted therapies to promote wellness. Our panelists will provide their unique perspectives on what the future holds for personalized medicine.

    Clay Wilemon, Chief Strategy Officer & President – Brand Activation, BRADO (Moderator)

    Steve Keiles, Senior Director, Genomic Services, Advanced Diagnostics, Quest Diagnostics

    Patrick Lilley, Founder & CEO, Liquid Biosciences

    Shaista Malik, MD, PhD, MPH, Associate Vice Chancellor, Integrative Health & Executive Director, Susan Samueli Integrative Health Institute

    Annette Walker, President, City of Hope Orange County

    10:00 - 10:30 AM
    Break & 1:1 Meetings
    10:30 - 11:15 AM
    Industry Track: What’s New in Clinical Trials

    This panel will discuss requirement of Clinical Trails, educate attendees on domestic vs international options for clinical trails and why trials matter for clearance, CMS and marketing.

    Bruce Feuchter, Shareholder, Stradling (Moderator)

    Bobak Azamian, MD, PhD, CEO, Tarsus Pharmaceuticals

    Marina Bejanian, PhD, Executive Director, Clinical Development, Allergan

    Janice Sidorick, CEO, Janix (CRO)


    10:30 - 11:15 AM
    International Track: EU Regulatory Update: MDR/IVDR/ Brexit

    An update on current status of BREXIT. What does BREXIT mean for companies in the US and Britain? What are the tax and legal implications? What are the implications for doing business in the rest of Europe?

    Kevin Depew, Deputy Chief Economist, RSM (Moderator)

    Alison Dennis, Partner, Field Fisher

    Mike Howells, Consul General, British Consulate

    Patrick Johnson, President & CEO, Celluma

    11:15 - 11:45 AM
    Break & 1x1 Meetings
    11:45 - 12:45 PM
    Lunch: Keynote Speaker- Jim Fallon, Professor, UCI, Neuroscientist, Best Selling Author

    Through research he explores the way genetic and perinatal environmental factors affect the way the brain gets built — and then how an individual’s experience further shapes his or her development. But Fallon’s research on psychopaths and murderers made a strange and personal turn. With PET scans and genetics , he uncovered the deep, underlying traits that make people violent and murderous.

    Introduction & Q&A: Linda DiMario, Executive Vice President, Greater Irvine Chamber of Commerce

    Jim Fallon, Professor, UCI, Neuroscientist

    12:45 - 01:15 PM
    Break & 1x1 Meetings
    01:15 - 02:00 PM
    Industry Track: Heathcare-On-The-Go

    Panel participants will focus on the future of care, the changing medical landscape, and whether telemedicine makes healthcare more affordable.

    Jessica Achtsam, Partner, Knobbe Martens (Moderator)

    Robert Allison, Principal & Managing Director, Innovate Partners

    Justin Zaghi, MD, Medical Director, Heal.com

    Jenna Mons, CEO CONCIERGE KEY Health, Inc.

    01:15 - 02:00 PM
    International Track: Reality Check-Doing Business in China

    This session will focus on the the challenges of doing business in China: avoiding the pitfalls and how to find trusted partners while doing business in the country.

    John Cox, President & CEO, FRESCA Medical (Moderator)

    Chris Lo, Director, Hong Kong Trade Development Council

    Paul DeRidder, MD, MBA, President, BioValleyCHINA

    Grace Fu Palma, President and CEO of ChinaMed Device LLC

    Andrew Pan, Senior Vice President, Head of China Business & Strategy, East West Bank’s

    02:00 - 02:45 PM
    The Innovation Agenda – Getting Life Saving Products to Market

    Overall – Despite the pressure to improve efficiency and reduce costs, medtech companies are still looking to innovate. Companies are looking to non-traditional partners to help drive innovation agenda and collaborate with outside organizations. How is the financial pressure from health care reform, the transition to value-based health care, tougher insurance coverage and increased regulatory requirements affecting innovation? The panelists discuss innovation and what they see in the future of innovation in medtech.

    Len Brandt, General Partner, Norwest Ventures (Moderator)

    Irina Kulinets, PhD, RAC, CQE, Sr. Vice President of Regulatory

    Affairs, Clinical Research & Quality, MicroVention, Inc., A TERUMO Group Company (Moderator)

    Daniela A. Bota, MD, PhD, Neuro-Oncology, UC Irvine

    Jonathon Lobbins, Vice President, Advanced Therapies, Siemens Healthineers


    02:00 - 02:45 PM
    Industry Track: Future of Mental Health

    Hear from leaders of Be Well OC- a transformative first of its kind-initiative bringing together public, private, academic and faith based organizations to coordinate a coordinated system of mental health and support. What is the latest innovation in mental health treatment? How do you personalize treatment?

    Richard Afable, MD, MPH, President & Board Member, MindOC (Moderator)

    Clayton Chau, MD, PhD, Chief Clinical Officer, MindOC

    Marshall Monchief, CEO, MindOC

    02:45 - 03:15 PM
    Break & 1x1 Meetings
    03:15 - 04:15 PM
    Panel Discussion: Medical Innovation in Aesthetics

    Panelists in this session will facilitate the exchange of insights on emerging trends and innovation in medical aesthetics.

    Scott Whitcup, MD, Founder and CEO, Akrivista and Whitecap Biosciences (Moderator)

    Natasha Mesinkovska, MD, Dermatology Specialist, UC Irvine Medical Center

    Darin Messina, PhD, Vice President of Device Biology R&D, Allergan

    Edward Ross, MD, Dermatologist, Scripps

    Steve Yoelin, MD, Cosmetic Surgeon

    Chris Zachary, MD, Chair & Professor – Dermatology, UC Irvine School of Medicine

    04:15 - 05:00 PM
    Panel Discussion: The State of Affairs for Medical Cannabis

    Despite its controversial nature, medical marijuana use and legal adoption continues to expand nationwide.

    Kim Kovacs, Managing Director of Arroyo Ventures, President, Los Angeles Venture Association (LAVA), & Founderr, MyJane (Moderator)

    Ashley Chiu, Cannabis Strategy and Risk Advisor, EY

    Mara Gordon, Co-founder & Chief Process Engineer, The Oil Plant

    Thomas Marcotte, MD, Co-Director, Center for Medicinal Cannabis Research – UC San Diego

    Amy Oppedisano, Co- Founder, Terra Tech Corp. (Owner of Blüm)

    Robert Solomon, Co-Chair, UCI Center for the Study of Cannabis

    05:00 - 05:15 PM
    Closing Day 1
    05:15 - 06:30 PM

    Medical Technology Innovation Forum

    October 28-29, 2019
    Newport Beach Marriott Hotel & Spa

    Join Our Ecosystem

    We’ll keep you updated on all things OCTANe.

    OCTANe values your privacy. Please view our privacy policy here.


    65 Enterprise
    Aliso Viejo, CA 92656